Continue with FacebookLooking to list your PhD opportunities? Log in here.
ovarian PhD Projects, Programmes & Scholarships
We have 17 ovarian PhD Projects, Programmes & Scholarships
PhD saved successfully
Vibrational spectroscopy of minimally invasive biofluids for early detection of ovarian and endometrial cancer
To submit an application please complete the form at. https://forms.office.com/r/wzGYFFKu1t. This PhD project will be based in the Radiation and Environmental Science Centre (RESC), Technological University Dublin (Prof. Read more
Last chance to apply
Validation of test strategies for the identification of adverse effects of chemicals on the human fetal ovarian development
The European FREIA project. , which both supervisors are part of, is specifically designed to address how female reproductive health can be safeguarded from endocrine disrupting chemicals (EDCs). Read more
To investigate novel interacting drug combinations in the treatment of Ovarian Cancer
Ovarian cancer (OC), the most lethal gynaecological cancer, will result in ~13,000 deaths in the UK this year. At time of diagnosis most patients (58%)… Read more
P97-UFD1-LARP1 axis regulates autophagy and PARP inhibitor resistance in ovarian cancer
Ovarian cancer (OC) is the most lethal gynaecological malignancy. Read more
New anticancer therapies based on transition metal complexes
Cancer is one of the leading causes of death around the world. Over 50% of cancer tumours are treated with platinum-based metal complexes, like cisplatin and its derivatives. Read more
Tumour microenvironment and metabolism
About us. The CRUK Beatson Institute where the lab is based is a world leading cancer research institute, situated in the vibrant city of Glasgow in Scotland and hosting approximately 60 postdoctoral researcher scientists at any one time. Read more
The effects of different [supraphysiological] concentrations of oestrogen and progesterone on aspects of physiological functioning and performance in cis-gender women
There is a shortage of high-quality data relating to female endocrinology and exercise physiology. This lack of knowledge and understanding has limited the appliance of science in active women (i.e., within a sport and exercise science context). Read more
Using human genetics to identify novel biomarkers for enhanced prediction and early detection of cancer
The student will use a novel human genetics approach (“Reverse Mendelian randomization”) to identify plasma protein markers for early detection of cancer. Read more
Deep learning enabled alternative drug design for cancer patients
We invite applications from research students interested in learning and developing an understanding of deep learning-based solutions for drug design for cancer chemotherapy. Read more
Synthesis of New Anti-Cancer Agents and Pharmacogenomics of BRCA-mutated Cancers in the Qatar Population
The group has published on the discovery of heterocyclic quinone anti-cancer agents with specificity towards hypoxic cells associated with solid tumours… Read more
Identification of novel combination therapies exploiting nucleotide metabolism and DNA repair to treat cancer
Nucleotide analogues (antimetabolites) are used as anti-cancer treatments in the clinic for many decades, most commonly for the treatment of haematological, breast, ovarian and intestinal cancers. Read more
Defining the transcription roles of BRCA1 and BRCA2
BRCA1 and BRCA2 mutations predispose to both breast and ovarian cancers, with both factors playing many crucial roles in DNA damage repair and response. Read more
Developing novel therapeutic strategies to better treat Triple Negative Breast Cancer
One in two people will develop cancer in their lifetime and it is a leading cause of death. While significant progress has been made in the treatment of some cancers, there still remain some forms of the disease with limited treatment options and poor outcome. Read more
How does paclitaxel kill cells and why do some cells evade it?
Paclitaxel (Taxol) is a microtubule-stabilizing drug widely used for the treatment of breast, ovarian and lung cancers. For many years, it was thought to kill cancer cells by inducing mitotic arrest, thus preventing proliferation. Read more
Investigating the role of USP17 in intracellular trafficking
USP17 is over-expressed in a range of primary tumours including NSCLC, breast, colorectal, cervical, ovarian and osteosarcoma and its depletion has been shown to block the growth, and migration, of cells from all these cancer types. Read more
- 1
- 2
